Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Fitoterapia ; 175: 105924, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38537886

RESUMEN

Alzheimer's disease (AD) is a progressive neurodegenerative disease, and accumulating evidence suggested that proteostatic imbalance is a key feature of the disease. Traditional Chinese medicine exhibits a multi-target therapeutic effect, making it highly suitable for addressing protein homeostasis imbalance in AD. Dendrobium officinale is a traditional Chinese herbs commonly used as tonic agent in China. In this study, we investigated protection effects of D. officinale phenolic extract (SH-F) and examined its underlying mechanisms by using transgenic Caenorhabditis elegans models. We found that treatment with SH-F (50 µg/mL) alleviated Aß and tau protein toxicity in worms, and also reduced aggregation of polyglutamine proteins to help maintain proteostasis. RNA sequencing results showed that SH-F treatment significantly affected the proteolytic process and autophagy-lysosomal pathway. Furthermore, we confirmed that SH-F showing maintainance of proteostasis was dependent on bec-1 by qRT-PCR analysis and RNAi methods. Finally, we identified active components of SH-F by LC-MS method, and found the five major compounds including koaburaside, tyramine dihydroferulate, N-p-trans-coumaroyltyramine, naringenin and isolariciresinol are the main bioactive components responsible for the anti-AD activity of SH-F. Our findings provide new insights to develop a treatment strategy for AD by targeting proteostasis, and SH-F could be an alternative drug for the treatment of AD.


Asunto(s)
Enfermedad de Alzheimer , Péptidos beta-Amiloides , Autofagia , Caenorhabditis elegans , Dendrobium , Modelos Animales de Enfermedad , Extractos Vegetales , Proteostasis , Animales , Caenorhabditis elegans/efectos de los fármacos , Enfermedad de Alzheimer/tratamiento farmacológico , Dendrobium/química , Proteostasis/efectos de los fármacos , Autofagia/efectos de los fármacos , Péptidos beta-Amiloides/metabolismo , Extractos Vegetales/farmacología , Animales Modificados Genéticamente , Proteínas tau/metabolismo , Fenoles/farmacología , Fenoles/aislamiento & purificación , Flavanonas/farmacología , Medicamentos Herbarios Chinos/farmacología , Fitoquímicos/farmacología , Fitoquímicos/aislamiento & purificación
2.
J Med Chem ; 64(18): 13475-13486, 2021 09 23.
Artículo en Inglés | MEDLINE | ID: mdl-34506131

RESUMEN

Beclin 1 is an essential autophagy gene and a haploinsufficient tumor suppressor. Beclin 1 is the scaffolding member of the Class III phosphatidylinositol-3-kinase complex (PI3KC3) and recruits two positive regulators Atg14L and UVRAG through its coiled-coil domain to upregulate PI3KC3 activity. Our previous work has shown that hydrocarbon-stapled peptides targeted to the Beclin 1 coiled-coil domain reduced Beclin 1 homodimerization and promoted the Beclin 1-Atg14L/UVRAG interaction. These peptides also induced autophagy and enhanced the endolysosomal degradation of cell surface receptors like EGFR. Here, we present the optimization of these Beclin 1-targeting peptides by staple scanning and sequence permutation. Placing the hydrocarbon staple closer to the Beclin 1-peptide interface enhanced their binding affinity by ∼10- to 30-fold. Optimized peptides showed potent antiproliferative efficacy in cancer cells that overexpressed EGFR and HER2 by inducing necrotic cell death but not apoptosis. Our Beclin 1-targeting stapled peptides may serve as effective therapeutic candidates for EGFR- or HER2-driven cancer.


Asunto(s)
Antineoplásicos/farmacología , Beclina-1/metabolismo , Proliferación Celular/efectos de los fármacos , Péptidos/farmacología , Secuencia de Aminoácidos , Antineoplásicos/química , Autofagia/efectos de los fármacos , Línea Celular Tumoral , Diseño de Fármacos , Receptores ErbB/metabolismo , Células HEK293 , Humanos , Lisosomas/efectos de los fármacos , Lisosomas/metabolismo , Necrosis/inducido químicamente , Péptidos/química , Conformación Proteica , Proteolisis , Receptor ErbB-2/metabolismo
3.
Biomed Pharmacother ; 133: 111005, 2021 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-33378996

RESUMEN

BACKGROUND: The dried root and rhizome of Aster tataricus (RA), is a traditional Chinese medicine has been used for more than 2000 years with the function of antitussive, expectorant and antiasthmatic. Ancient books and modern pharmacological researches demonstrated that RA may have the function of moistening intestines and relieving constipation, but there was a lack of systematic evidence. The aim of this study was to comprehensively evaluate the efficacy and possible mechanisms of ethanol extract of Aster tataricus (ATE) in treating constipation from in vivo to in vitro. METHODS: In vivo, the ATE was studied in loperamide-induced constipation of mice. In vitro, different concentrations of ATE was tested separately or cumulatively on spontaneous and agonists-induced contractions of isolated rat duodenum strips. RESULTS: In vivo, at doses of 0.16, 0.8 g/mL, ATE showed significantly promotion of the small intestinal charcoal transit, decrease of the amount of remnant fecal, and increase of the content of fecal water in colon. In addition, ATE could effectively relieve colonic pathological damage caused by loperamide as well. In vitro, with the cumulative concentration increase of ATE from 0.8 to 6.4 mg/mL, it could significantly decrease the contraction caused by KCl or Ach, and gradually restore to near base tension value.Meanwhile, it could also partially but significantly inhibit the contractions induced by Ach and CaCl2 on rat duodenum in a concentration related manner. CONCLUSIONS: Taking all these findings together, it could be speculated that ATE may attenuate constipation mainly through antagonizing the binding of acetylcholine to muscarinic receptor, inhibiting Ca2+ influx and anti-inflammation.


Asunto(s)
Aster , Señalización del Calcio/efectos de los fármacos , Estreñimiento/tratamiento farmacológico , Defecación/efectos de los fármacos , Duodeno/efectos de los fármacos , Tránsito Gastrointestinal/efectos de los fármacos , Laxativos/farmacología , Antagonistas Muscarínicos/farmacología , Extractos Vegetales/farmacología , Animales , Antiinflamatorios/aislamiento & purificación , Antiinflamatorios/farmacología , Aster/química , Estreñimiento/inducido químicamente , Estreñimiento/metabolismo , Estreñimiento/fisiopatología , Modelos Animales de Enfermedad , Duodeno/metabolismo , Duodeno/fisiopatología , Laxativos/aislamiento & purificación , Loperamida , Ratones , Antagonistas Muscarínicos/aislamiento & purificación , Extractos Vegetales/aislamiento & purificación , Ratas Sprague-Dawley
4.
Biogerontology ; 21(2): 245-256, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-31960183

RESUMEN

Coix seed oil (CSO) has many beneficial effects, but there is limited research on its influence on the processes and mechanisms related to senescence. Here, we used Caenorhabditis elegans as an in vivo model to investigate CSO's bioeffects on longevity. CSO (1 mg/mL) significantly extended the mean lifespan of C. elegans by over 22.79% and markedly improved stress resistance. Gene-specific mutant studies showed that the CSO-mediated increase in life expectancy was dependent on mev-1, hsf-1 and daf-16, but not daf-2. Furthermore, CSO significantly upregulated stress-inducible genes, including daf-16 and its downstream genes (sod-3, hsp-16.2 and gst-4). In addition, four major fatty acids, linoleic, oleic, palmitic and stearic, played leading roles in C. elegans' extended lifespan. Thus, CSO increased the life expectancy of, and enhanced the stress resistance in, C. elegans mainly through daf-16 and its downstream genes, but not through the insulin/insulin-like growth factor 1 signaling pathway.


Asunto(s)
Caenorhabditis elegans/efectos de los fármacos , Coix , Longevidad/efectos de los fármacos , Aceites de Plantas/administración & dosificación , Semillas , Estrés Fisiológico/efectos de los fármacos , Animales , Animales Modificados Genéticamente , Caenorhabditis elegans/genética , Caenorhabditis elegans/metabolismo , Proteínas de Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/metabolismo , Coix/química , Citocromos b/genética , Citocromos b/metabolismo , Factores de Transcripción Forkhead/genética , Factores de Transcripción Forkhead/metabolismo , Regulación de la Expresión Génica , Aceites de Plantas/aislamiento & purificación , Semillas/química , Estrés Fisiológico/genética , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
5.
Zhongguo Zhong Yao Za Zhi ; 44(5): 948-953, 2019 Mar.
Artículo en Chino | MEDLINE | ID: mdl-30989854

RESUMEN

Longshengzhi capsule consisting of 12 herbs is widely used in clinically treating cerebral ischemia during recovery period.In this study,in order to investigate the consistency of different batches of Longshengzhi capsules,a high performance liquid chromatography coupled to triple quadrupole mass spectrometry method(HPLC-QQQ/MS) was developed for the determination of 19 representative components in Longshengzhi Capsules within 9 min. Methodology validation indicated this method was simple,rapid,accurate,highly sensitive and reproducible,and it could be used for the content determination of components in Longshengzhi Capsules. The consistency analysis results showed that paeoniflorin and calycosin-7-glucoside in Longshengzhi Capsules had the highest content; RSD value of total content of 19 compounds was 5. 2% and the RSD value of main compounds such as astragaloside and calycosin-7-glucoside was all less than 15%,reflecting good consistency among different batches. This study has provided a scientific method and basis for the quality control and consistency evaluation of Longshengzhi Capsules.


Asunto(s)
Medicamentos Herbarios Chinos/análisis , Medicamentos Herbarios Chinos/normas , Cápsulas , Cromatografía Líquida de Alta Presión , Espectrometría de Masas , Reproducibilidad de los Resultados
6.
Biosci Rep ; 39(3)2019 03 29.
Artículo en Inglés | MEDLINE | ID: mdl-30770400

RESUMEN

Unstable angina pectoris (UA) is one of the most dangerous clinical symptoms of acute coronary syndrome due to the risk of myocardial ischemia, which can lead to high morbidity and mortality worldwide. Though there are many advantages in understanding the pathophysiology of UA, the identification of biomarkers for the diagnosis, prognosis, and treatment of UA remains a challenge in the clinic. A global metabolomics research based on ultra-performance liquid chromatography (UPLC) combined with Q-TOF/MS was performed to discover the metabolic profile of health controls, UA patients, and UA patients with diabetes mellitus (DM), and screen for potential biomarkers. Twenty-seven potential biomarkers were determined using pattern recognition. These biomarkers, which include free fatty acids, amino acids, lysoPE and lysoPC species, and organic acids, can benefit the clinical diagnosis of UA. Pathway analysis indicated that arginine and proline metabolism, glycerophospholipid metabolism, and purine metabolism were affected in the UA patients, uniquely. Additionally, alterations in the metabolic signatures between UA and UA-complicated DM were also explored. As a result, six differential metabolites with an area under the curve (AUC) of more than 0.85 were identified as biomarkers for the diagnosis of UA and UA complicated with DM. Pathway analysis implied tryptophan metabolism was a key metabolic pathway in UA patients with DM, which provides new insights into the pathological study and drug discovery of UA.


Asunto(s)
Angina Inestable/metabolismo , Biomarcadores/sangre , Diabetes Mellitus/metabolismo , Metaboloma , Metabolómica/métodos , Adulto , Anciano , Aminoácidos/sangre , Angina Inestable/sangre , Angina Inestable/diagnóstico , Diabetes Mellitus/sangre , Ácidos Grasos no Esterificados/sangre , Femenino , Humanos , Masculino , Redes y Vías Metabólicas , Persona de Mediana Edad , Pronóstico , Sensibilidad y Especificidad , Adulto Joven
7.
FASEB J ; 33(3): 3496-3509, 2019 03.
Artículo en Inglés | MEDLINE | ID: mdl-30517036

RESUMEN

Coculture of mesenchymal stem cells (MSCs) and vascular endothelial cells (ECs) in vitro leads to the formation of a capillary-like reticular structure by ECs, which has great potential as a better substitute for artificial blood vessels in terms of stability and functionality. To investigate the mechanisms of the early neovascularization induced by MSCs, we analyzed the kinematic features of the motion of ECs and concluded that the dynamic interaction between cells and the extracellular matrix would reveal the capillary-like structure formation. Based on this hypothesis, we proposed a mathematical model to simulate the vascular-like migration pattern of ECs in silico, which was confirmed by in vitro studies. These in vitro studies validated that the dynamic secretion and degradation of collagen I is the critical factor for capillary structure formation. The model proposed based on cell tracking, single cell sequencing, and mathematical simulation provides a better understanding of the neovascularization process induced by MSCs and a possible simple explanation guiding this important cellular behavior.-Yu, Y., Situ, Q., Jia, W., Li, J., Wu, Q., Lei, J. Data driven mathematical modeling reveals the dynamic mechanism of MSC-induced neovascularization.


Asunto(s)
Células Madre Mesenquimatosas/patología , Neovascularización Patológica/patología , Capilares/metabolismo , Capilares/patología , Células Cultivadas , Técnicas de Cocultivo/métodos , Colágeno Tipo I/metabolismo , Células Endoteliales/patología , Matriz Extracelular/metabolismo , Células HEK293 , Células Endoteliales de la Vena Umbilical Humana , Humanos , Células Madre Mesenquimatosas/metabolismo , Modelos Teóricos , Neovascularización Patológica/metabolismo
8.
Free Radic Biol Med ; 129: 310-322, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30266681

RESUMEN

Lonicera japonica (LJ) is widely used as the local medicine to improve body and prevent ills in China, but mechanisms of its healthy beneficial effects remain largely unclear. Here, we evaluated the anti-aging and healthspan promoting activities of 75% ethanol extract of LJ (LJ-E) in the animal model Caenorhabditis elegans. Our results showed that LJ-E (500 µg/mL) treatment enhanced the mean lifespan of worms by over 21.87% and significantly improved age-associated physiological functions in C. elegans. The 500 µg/mL concentration of LJ-E enhanced the survival rates under oxidative and thermal stresses, and decreased reactive oxygen species (ROS) levels and fat accumulation in the worms. Gene-specific mutant studies showed that LJ-E-mediated lifespan extension was dependent on mev-1, daf-2, daf-16, and hsf-1, but not eat-2 genes. LJ-E could upregulate stress-inducible genes, viz., hsp-16.2, sod-3 and mtl-1. Moreover, we found that the D1086.10 protein interacted with superoxide dismutase (SOD)-3 by functional protein association networks analysis according to RNA-sequencing results. It was confirmed that D1086.10 was needed to promote longevity, and positively regulated expression of sod-3 by using D1086.10 mutants. Furthermore, LJ-E significantly delayed amyloid ß-protein induced paralysis in CL4176 strain. Given the important role of autophagy in aging and protein homeostasis, we observed that LJ-E could remarkably increase the mRNA expression of autophagy gene bec-1 in CL4176 strain, and decrease expression of autophagy substrate p62 protein by more than 40.0% in BC12921 strain. Finally, we found that combination composed of three major compounds (54 µg/mL chlorogenic acid, 15 µg/mL 1,5-dicaffeoylquinic acid and 7.5 µg/mL 1,3-dicaffeoylquinic acid) of 500 µg/mL LJ-E could significantly delay paralysis in CL4176 worms caused by Aß toxicity, comparable to that of LJ-E. Overall, our study may have important implications in using Lonicera japonica to promote healthy aging and have a potency to design therapeutics for age-related diseases.


Asunto(s)
Caenorhabditis elegans/efectos de los fármacos , Medicamentos Herbarios Chinos/farmacología , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Longevidad/efectos de los fármacos , Lonicera/química , Especies Reactivas de Oxígeno/antagonistas & inhibidores , Tejido Adiposo/efectos de los fármacos , Tejido Adiposo/crecimiento & desarrollo , Tejido Adiposo/metabolismo , Péptidos beta-Amiloides/genética , Péptidos beta-Amiloides/metabolismo , Animales , Caenorhabditis elegans/genética , Caenorhabditis elegans/crecimiento & desarrollo , Caenorhabditis elegans/metabolismo , Proteínas de Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/metabolismo , Ácido Clorogénico/farmacología , Cinamatos/farmacología , Citocromos b/genética , Citocromos b/metabolismo , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/aislamiento & purificación , Factores de Transcripción Forkhead/genética , Factores de Transcripción Forkhead/metabolismo , Proteínas de Choque Térmico/genética , Proteínas de Choque Térmico/metabolismo , Longevidad/genética , Metalotioneína/genética , Metalotioneína/metabolismo , Parálisis/prevención & control , Ácido Quínico/análogos & derivados , Ácido Quínico/farmacología , Especies Reactivas de Oxígeno/metabolismo , Receptor de Insulina/genética , Receptor de Insulina/metabolismo , Estrés Fisiológico , Superóxido Dismutasa/genética , Superóxido Dismutasa/metabolismo , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Proteínas de Transporte Vesicular/genética , Proteínas de Transporte Vesicular/metabolismo
9.
Sci Rep ; 7(1): 11020, 2017 09 08.
Artículo en Inglés | MEDLINE | ID: mdl-28887548

RESUMEN

Leveraging microfluidics and nano-plasmonics, we present in this paper a new method employing a micro-nano-device that is capable of monitoring the dynamic cell-substrate attachment process at single cell level in real time without labeling. The micro-nano-device essentially has a gold thin film as the substrate perforated with periodic, near-cm2-area, template-stripped nano-holes, which generate plasmonic extraordinary optical transmission (EOT) with a high sensitivity to refractive index changes at the metal-dielectric interface. Using this device, we successfully demonstrated label-free and real-time monitoring of the dynamic cell attachment process for single mouse embryonic stem cell (C3H10) and human tumor cell (HeLa) by collecting EOT spectrum data during 3-hour on-chip culture. We further collected the EOT spectral shift data at the start and end points of measurement during 3-hour on-chip culture for 50 C3H10 and 50 HeLa cells, respectively. The experiment results show that the single cell attachment process of both HeLa and C3H10 cells follow the logistic retarded growth model, but with different kinetic parameters. Variations in spectral shift during the same culture period across single cells present new evidence for cell heterogeneity. The micro-nano-device provides a new, label-free, real-time, and sensitive, platform to investigate the cell adhesion kinetics at single cell level.


Asunto(s)
Adhesión Celular , Células Epiteliales/fisiología , Microfluídica/métodos , Células Madre Embrionarias de Ratones/fisiología , Análisis de la Célula Individual/métodos , Animales , Células HeLa , Humanos , Ratones , Microfluídica/instrumentación , Análisis de la Célula Individual/instrumentación
10.
Biotechnol Lett ; 39(2): 179-188, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27815758

RESUMEN

OBJECTIVE: RNAe is a new method that enhances protein expression at the post-transcriptional level. RNAe utility was further explored to improve endogenous protein expression. RESULTS: Transgenic mice were created by targeting RNAe to growth hormone gene into the C57/BL mouse genome by transposon mediated integration; the mice showed a heavier body weight and longer body length compared with normal mice. RNAe can also be used for gene therapy through the delivery of in vitro transcribed RNA. CONCLUSION: This study takes a further step towards applying RNAe in pharmaceutical approaches by transposon-based transgenic mice model construction and the use of in vitro transcribed RNA transfection assay.


Asunto(s)
Hormona del Crecimiento/genética , ARN Largo no Codificante/genética , ARN Mensajero/genética , Animales , Línea Celular , Ensayo de Inmunoadsorción Enzimática , Femenino , Citometría de Flujo , Terapia Genética/métodos , Células HeLa , Humanos , Masculino , Ratones , Ratones Transgénicos , Embarazo
11.
Mol Ther Nucleic Acids ; 5: e318, 2016 May 03.
Artículo en Inglés | MEDLINE | ID: mdl-27138178

RESUMEN

Targeted therapy for cancer is a research area of great interest, and magnetic nanoparticles (MNPs) show great potential as targeted carriers for therapeutics. One important class of cancer biomarkers is microRNAs (miRNAs), which play a significant role in tumor initiation and progression. In this study, a cascade recognition system containing multiple plasmids, including a Tet activator, a lacI repressor gene driven by the TetOn promoter, and a reporter gene repressed by the lacI repressor and influenced by multiple endogenous miRNAs, was used to recognize cells that display miRNA signals that are characteristic of cancer. For this purpose, three types of signal miRNAs with high proliferation and metastasis abilities were chosen (miR-21, miR-145, and miR-9). The response of this system to the human breast cancer MCF-7 cell line was 3.2-fold higher than that to the human breast epithelial HBL100 cell line and almost 7.5-fold higher than that to human embryonic kidney HEK293T cells. In combination with polyethyleneimine-modified MNPs, this recognition system targeted the tumor location in situ in an animal model, and an ~42% repression of tumor growth was achieved. Our study provides a new combination of magnetic nanocarrier and gene therapy based on miRNAs that are active in vivo, which has potential for use in future cancer therapies.

12.
Nucleic Acids Res ; 43(9): e58, 2015 May 19.
Artículo en Inglés | MEDLINE | ID: mdl-25722369

RESUMEN

In this study, a universal protein expression enhancement RNA tool, termed RNAe, was developed by modifying a recently discovered natural long non-coding RNA. At the moment, RNAe is the only technology for gene expression enhancement, as opposed to silencing, at the post-transcriptional level. With this technology, an expression enhancement of 50-1000% is achievable, with more than 200% enhancement achieved in most cases. This work identified the sufficient and necessary element for RNAe function, which was found to be merely 300 nucleotides long and was named minRNAe. It contains a 72-nt 5' pairing sequence which determines the specificity, a 167-nt short non-pairing interspersed nuclear element (SINE) B2 sequence which enhances ribosome recruitment to the target mRNA, and a poly(A) tail, provided together on a plasmid bearing the appropriate sequences. Cellular delivery of RNAe was achieved using routine transfection. The RNAe platform was validated in several widely-used mammalian cell lines. It was proven to be efficient and flexible in specifically enhancing the expression of various endogenous and exogenous proteins of diverse functions in a dose-dependent manner. Compared to the expression-inhibitory tool RNAi, the RNAe tool has a comparable effect size, with an enhancing as opposed to inhibitory effect. One may predict that this brand new technology for enhancing the production of proteins will find wide applications in both research and biopharmaceutical production.


Asunto(s)
Regulación de la Expresión Génica , Biosíntesis de Proteínas , Ingeniería de Proteínas/métodos , ARN Largo no Codificante/química , Formación de Anticuerpos , Línea Celular , Vectores Genéticos , Proteínas Fluorescentes Verdes/análisis , Proteínas Fluorescentes Verdes/genética , Células HEK293 , Humanos , Proteómica , ARN sin Sentido/química , Secuencias Repetitivas de Ácidos Nucleicos , Ribosomas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA